These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 11135730

  • 1. Cytochrome P-450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes.
    Court MH, Duan SX, Hesse LM, Venkatakrishnan K, Greenblatt DJ.
    Anesthesiology; 2001 Jan; 94(1):110-9. PubMed ID: 11135730
    [Abstract] [Full Text] [Related]

  • 2. Cytochrome P4502B6 and 2C9 do not metabolize midazolam: kinetic analysis and inhibition study with monoclonal antibodies.
    Hamaoka N, Oda Y, Hase I, Asada A.
    Br J Anaesth; 2001 Apr; 86(4):540-4. PubMed ID: 11573629
    [Abstract] [Full Text] [Related]

  • 3. CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.
    Hesse LM, Venkatakrishnan K, Court MH, von Moltke LL, Duan SX, Shader RI, Greenblatt DJ.
    Drug Metab Dispos; 2000 Oct; 28(10):1176-83. PubMed ID: 10997936
    [Abstract] [Full Text] [Related]

  • 4. Possible involvement of multiple human cytochrome P450 isoforms in the liver metabolism of propofol.
    Guitton J, Buronfosse T, Desage M, Flinois JP, Perdrix JP, Brazier JL, Beaune P.
    Br J Anaesth; 1998 Jun; 80(6):788-95. PubMed ID: 9771309
    [Abstract] [Full Text] [Related]

  • 5. Involvement of human cytochrome P450 2B6 in the omega- and 4-hydroxylation of the anesthetic agent propofol.
    Murayama N, Minoshima M, Shimizu M, Guengerich FP, Yamazaki H.
    Xenobiotica; 2007 Jul; 37(7):717-24. PubMed ID: 17620218
    [Abstract] [Full Text] [Related]

  • 6. Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity.
    Faucette SR, Hawke RL, Lecluyse EL, Shord SS, Yan B, Laethem RM, Lindley CM.
    Drug Metab Dispos; 2000 Oct; 28(10):1222-30. PubMed ID: 10997944
    [Abstract] [Full Text] [Related]

  • 7. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.
    Lasker JM, Wester MR, Aramsombatdee E, Raucy JL.
    Arch Biochem Biophys; 1998 May 01; 353(1):16-28. PubMed ID: 9578596
    [Abstract] [Full Text] [Related]

  • 8. Involvement of human liver cytochrome P4502B6 in the metabolism of propofol.
    Oda Y, Hamaoka N, Hiroi T, Imaoka S, Hase I, Tanaka K, Funae Y, Ishizaki T, Asada A.
    Br J Clin Pharmacol; 2001 Mar 01; 51(3):281-5. PubMed ID: 11298076
    [Abstract] [Full Text] [Related]

  • 9. Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1/*1 genotype.
    Kiang TK, Ho PC, Anari MR, Tong V, Abbott FS, Chang TK.
    Toxicol Sci; 2006 Dec 01; 94(2):261-71. PubMed ID: 16945988
    [Abstract] [Full Text] [Related]

  • 10. Evidence for propofol hydroxylation by cytochrome P4502B11 in canine liver microsomes: breed and gender differences.
    Hay Kraus BL, Greenblatt DJ, Venkatakrishnan K, Court MH.
    Xenobiotica; 2000 Jun 01; 30(6):575-88. PubMed ID: 10923860
    [Abstract] [Full Text] [Related]

  • 11. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM, Murray M.
    J Pharmacol Exp Ther; 1997 Feb 01; 280(2):966-73. PubMed ID: 9023313
    [Abstract] [Full Text] [Related]

  • 12. The role of CYP2C in the in vitro bioactivation of the contraceptive steroid desogestrel.
    Gentile DM, Verhoeven CH, Shimada T, Back DJ.
    J Pharmacol Exp Ther; 1998 Dec 01; 287(3):975-82. PubMed ID: 9864282
    [Abstract] [Full Text] [Related]

  • 13. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes.
    Rifkind AB, Lee C, Chang TK, Waxman DJ.
    Arch Biochem Biophys; 1995 Jul 10; 320(2):380-9. PubMed ID: 7625847
    [Abstract] [Full Text] [Related]

  • 14. Involvement of CYP2B6 in n-demethylation of ketamine in human liver microsomes.
    Yanagihara Y, Kariya S, Ohtani M, Uchino K, Aoyama T, Yamamura Y, Iga T.
    Drug Metab Dispos; 2001 Jun 10; 29(6):887-90. PubMed ID: 11353758
    [Abstract] [Full Text] [Related]

  • 15. Catalytic role of cytochrome P4502B6 in the N-demethylation of S-mephenytoin.
    Heyn H, White RB, Stevens JC.
    Drug Metab Dispos; 1996 Sep 10; 24(9):948-54. PubMed ID: 8886603
    [Abstract] [Full Text] [Related]

  • 16. Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms.
    Renwick AB, Surry D, Price RJ, Lake BG, Evans DC.
    Xenobiotica; 2000 Oct 10; 30(10):955-69. PubMed ID: 11315104
    [Abstract] [Full Text] [Related]

  • 17. Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation.
    Code EL, Crespi CL, Penman BW, Gonzalez FJ, Chang TK, Waxman DJ.
    Drug Metab Dispos; 1997 Aug 10; 25(8):985-93. PubMed ID: 9280407
    [Abstract] [Full Text] [Related]

  • 18. Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor.
    Tang C, Shou M, Mei Q, Rushmore TH, Rodrigues AD.
    J Pharmacol Exp Ther; 2000 May 10; 293(2):453-9. PubMed ID: 10773015
    [Abstract] [Full Text] [Related]

  • 19. Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes.
    Hijazi Y, Boulieu R.
    Drug Metab Dispos; 2002 Jul 10; 30(7):853-8. PubMed ID: 12065445
    [Abstract] [Full Text] [Related]

  • 20. Potent inhibition of cytochrome P450 2B6 by sibutramine in human liver microsomes.
    Bae SH, Kwon MJ, Choi EJ, Zheng YF, Yoon KD, Liu KH, Bae SK.
    Chem Biol Interact; 2013 Sep 05; 205(1):11-9. PubMed ID: 23777987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.